Abstract:Subarachnoid hemorrhage leads to a series of pathological changes, including vascular spasm, cellular apoptosis, blood-brain barrier damage, cerebral edema, and white matter injury. Microglia, which are the key immune cells in the central nervous system, maintain homeostasis in the neural environment, support neurons, mediate apoptosis, participate in immune regulation, and have neuroprotective effects. Increasing evidence has shown that microglia play a pivotal role in the pathogenesis of subarachnoid hemorrhage and affect the process of injury and the prognosis of subarachnoid hemorrhage. Moreover, microglia play certain neuroprotective roles in the recovery phase of subarachnoid hemorrhage. Several approaches aimed at modulating microglia function are believed to attenuate subarachnoid hemorrhage injury. This provides new targets and ideas for the treatment of subarachnoid hemorrhage. However, an in-depth and comprehensive summary of the role of microglia after subarachnoid hemorrhage is still lacking. This review describes the activation of microglia after subarachnoid hemorrhage and their roles in the pathological processes of vasospasm, neuroinflammation, neuronal apoptosis, blood-brain barrier disruption, cerebral edema, and cerebral white matter lesions. It also discusses the neuroprotective roles of microglia during recovery from subarachnoid hemorrhage and therapeutic advances aimed at modulating microglial function after subarachnoid hemorrhage. Currently, microglia in subarachnoid hemorrhage are targeted with TLR inhibitors, nuclear factor-κB and STAT3 pathway inhibitors, glycine/tyrosine kinases, NLRP3 signaling pathway inhibitors, Gasdermin D inhibitors, vincristine receptor α receptor agonists, ferroptosis inhibitors, genetic modification techniques, stem cell therapies, and traditional Chinese medicine. However, most of these are still being evaluated at the laboratory stage. More clinical studies and data on subarachnoid hemorrhage are required to improve the treatment of subarachnoid hemorrhage.

Potential therapeutic molecular targets for blood-brain barrier disruption after subarachnoid hemorrhage

Therapeutic potential of stem cells in subarachnoid hemorrhage

The blood–brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments

Immune-mediated disruption of the blood-brain barrier after intracerebral hemorrhage: Insights and potential therapeutic targets

Microglia Activation, Classification and Microglia-Mediated Neuroinflammatory Modulators in Subarachnoid Hemorrhage.

The mechanism and relevant mediators associated with neuronal apoptosis and potential therapeutic targets in subarachnoid hemorrhage

Aneurysmal subarachnoid hemorrhage: pathobiology, current treatment and future directions

Blood–brain barrier dysfunction following traumatic brain injury

Targeting oxidative stress and inflammatory response for blood-brain barrier protection in intracerebral hemorrhage

Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update

Molecular mechanisms of neuronal death in brain injury after subarachnoid hemorrhage

Toll-like Receptor-4 Pathway As a Possible Molecular Mechanism for Brain Injuries after Subarachnoid Hemorrhage

Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets

Pathophysiological Mechanisms and Potential Therapeutic Targets in Intracerebral Hemorrhage

Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke

The pivotal role of microglia in injury and the prognosis of subarachnoid hemorrhage

Progress in Research on TLR4-Mediated Inflammatory Response Mechanisms in Brain Injury after Subarachnoid Hemorrhage

Therapeutic potential of natural compounds in subarachnoid haemorrhage

Potential Therapeutic Strategies for Intracranial Aneurysms Targeting Aneurysm Pathogenesis

Ischemia Reperfusion Injury Induced Blood Brain Barrier Dysfunction and the Involved Molecular Mechanism

Brain Arteriovenous Malformation Biology Relevant to Hemorrhage and Implication for Therapeutic Development